Supreme Court Snubs Martin Shkreli’s Last-Ditch Bid to Avoid $64 Million Fine

by DTM | Posted on
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, arrives at federal court in the Brooklyn borough of New York, U.S., on Thursday, Aug. 3, 2017.

There were no generic alternatives to a lifesaving drug when Shkreli jacked up its price by more than $700 per pill in 2015.